Rachel Leheny
Amministratore Delegato presso CALCIMEDICA, INC.
Patrimonio netto: 630 060 $ in data 31/05/2024
Profilo
Rachel Anne Leheny founded Valence Life Sciences LLC in 2012, where she is working as Founding Managing Director from 2012 and Caxton Advantage Venture Partners in 2006, where she worked as Managing Director.
Dr. Leheny also currently works at CalciMedica, Inc. (US), as Chief Executive Officer & Director, CalciMedica, Inc., as Chief Executive Officer & Director from 2019, Valence Investments SPV IV LLC, as Director & Manager, DalCor Pharmaceuticals Canada, Inc., as Director, and Advantage Life Sciences Partners LLC, as Member.
Dr. Leheny also formerly worked at Hambrecht & Quist Group, Inc., as Managing Director from 1993 to 1998, Corthera, Inc., as Director, Anthera Pharmaceuticals, Inc., as Independent Director in 2011, Lehman Brothers, Inc., as Senior Vice President from 2000 to 2002, the University of California, Berkeley, as Faculty Member, Caxton Health Holdings LLC, as Principal, UBS Warburg, Inc., as Executive Vice President, and The Clearity Foundation, as Chief Operating Officer from 2015 to 2017.
Dr. Leheny received her doctorate degree in 1991 from The Trustees of Columbia University in The City of New York and undergraduate degree from Harvard College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CALCIMEDICA, INC.
1.03% | 31/03/2024 | 110 926 ( 1.03% ) | 630 060 $ | 31/05/2024 |
Posizioni attive di Rachel Leheny
| Società | Posizione | Inizio |
|---|---|---|
| CALCIMEDICA, INC. | Amministratore Delegato | 01/09/2019 |
DalCor Pharmaceuticals Canada, Inc.
 DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | - |
Valence Investments SPV IV LLC
 Valence Investments SPV IV LLC BiotechnologyHealth Technology Valence Investments SPV IV LLC engages in the provision of biotechnology services. The company is headquartered in New York, NY. | Direttore/Membro del Consiglio | - |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Amministratore Delegato | 26/03/2019 |
Valence Life Sciences LLC
 Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences LLC (Valence Life Sciences) is an venture capital firm founded in 2012 by Rachel Anne Leheny and Eric Wayne Roberts. The firm is headquartered in New York. | Fondatore | 01/01/2012 |
| Advantage Life Sciences Partners LLC | Corporate Officer/Principal | 24/09/2009 |
Precedenti posizioni note di Rachel Leheny
| Società | Posizione | Fine |
|---|---|---|
The Clearity Foundation
 The Clearity Foundation Investment Trusts/Mutual FundsMiscellaneous The Clearity Foundation is a non-profit organization that functions as a foundation or endowment. The private company is based in San Diego, CA. The company was founded by Laura K. Shawver. | Direttore operativo | 01/02/2017 |
Caxton Advantage Venture Partners
 Caxton Advantage Venture Partners Investment ManagersFinance Founded in 2004 by Eric Roberts and Rachel Leheny, Caxton Advantage Venture Partners is a venture capital firm located in New York City. | Fondatore | - |
| ANTHERA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/02/2011 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Rachel Leheny
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ANTHERA PHARMACEUTICALS, INC. | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Aziende private | 12 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Hambrecht & Quist Group, Inc.
 Hambrecht & Quist Group, Inc. Investment Banks/BrokersFinance Hambrecht & Quist Group, Inc. operates as a holding investment bank and provides securities brokerage services. The company is headquartered in San Francisco, CA. | Finance |
Corthera, Inc.
 Corthera, Inc. Pharmaceuticals: MajorHealth Technology Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA. | Health Technology |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
Caxton Advantage Venture Partners
Caxton Advantage Venture Partners Investment ManagersFinance Founded in 2004 by Eric Roberts and Rachel Leheny, Caxton Advantage Venture Partners is a venture capital firm located in New York City. | Finance |
| Advantage Life Sciences Partners LLC | |
Caxton Health Holdings LLC
 Caxton Health Holdings LLC Financial ConglomeratesFinance Caxton Health Holdings LLC operates as an investment firm. It focus on healthcare sectors, such as healthcare technologies, biopharmaceuticals, drug discovery technology and healthcare information technology. The company is headquartered in New York, NY. | Finance |
| UBS Warburg, Inc. | |
The Clearity Foundation
The Clearity Foundation Investment Trusts/Mutual FundsMiscellaneous The Clearity Foundation is a non-profit organization that functions as a foundation or endowment. The private company is based in San Diego, CA. The company was founded by Laura K. Shawver. | Miscellaneous |
Valence Life Sciences LLC
Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences LLC (Valence Life Sciences) is an venture capital firm founded in 2012 by Rachel Anne Leheny and Eric Wayne Roberts. The firm is headquartered in New York. | Finance |
DalCor Pharmaceuticals Canada, Inc.
DalCor Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology DalCor Pharmaceuticals Canada, Inc. develops precision treatments for cardiovascular diseases. It offers dalcetrapib, a cholesterol ester transfer protein (CETP) inhibitor, as a potential targeted treatment to address the residual cardiovascular risk in patients carrying a specific ADCY9 genetic profile. The company was founded by Andr? Roger Desmarais and is headquartered in Montreal, Canada. | Health Technology |
Valence Investments SPV IV LLC
Valence Investments SPV IV LLC BiotechnologyHealth Technology Valence Investments SPV IV LLC engages in the provision of biotechnology services. The company is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Rachel Leheny
